Sign in
Taking people in United StatesNo phase

Physical activity program for adults with intellectual disability

Tests a physical activity program with caregivers and coaches for adults with intellectual disability.

Key facts

Who runs it
University of North Carolina, Chapel Hill
Where
Chapel Hill and Fayetteville, United StatesSee the 2 sites
Trial code
Registry title
Physical Activity and Community EmPOWERment Project
Status
Recruiting
People taking part
376 people, planned
Started
10 Jan 2025
Expected to end
Jun 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • PACE Program
Record updated
23 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with intellectual disability who are not very active and show no signs of Alzheimer's disease or dementia. A caregiver and a coach also take part.

Age
Adults with intellectual disability: 18 years and older, no upper age limit.
Sex
All sexes can join.
Disease stage
A clinical diagnosis of intellectual disability, confirmed by test scores. No clinically elevated signs of Alzheimer's disease or dementia (score under 20 on the Dementia Screening Questionnaire).

Main reasons for not taking part

  • Diagnosis of Alzheimer's disease, dementia or related disorders
  • No medical clearance for moderate-to-vigorous physical activity
  • Average of more than 20 minutes a day of moderate-to-vigorous activity
  • Not living in North Carolina or Arkansas
  • No caregiver or guardian able and willing to take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • ages 18 and older with a prior clinical diagnosis of ID, confirmed by scores < 70 and + 90% on the Leiter-3 International Performance Scales and/or an adaptive behavior measure using the Vineland Adaptive Behavior Scales,
  • Medical clearance to participate in moderate-to-vigorous physical activity as determined by the American College of Sports Medicine (ACSM) preparticipation algorithm,
  • Adult does not show clinically elevated symptoms of Alzheimer's Disease (AD)/ Alzheimer's Disease and Related Dementias (ADRD) as indicated by a score of < 20 on the Dementia Screening Questionnaire for Individuals with Intellectual Disabilities
  • One caregiver/guardian is able and willing to participate
  • must tolerate at least 8 hours of daily wear-time of Actigraph device during initial assessment period (4 of 7 days),
  • must average 20 minutes or less of moderate to vigorous physical activity (MVPA) minutes per day (140 MVPA minutes or less across 7-day period measured during the initial assessment period, and
  • must reside in North Carolina or Arkansas
  • access to the internet and a mobile device,
  • has weekly contact with the adult participant with ID,
  • can converse and read in English to comprehend intervention materials and website content, and
  • must reside in North Carolina or Arkansas
  • ability to converse and read in English to comprehend and answer interview questions, (2) must care for an adult with ID who is willing to participate in the study,
  • must reside in North Carolina or Arkansas, and
  • must attend all study visits with adult with ID

Who cannot take part

  • Diagnosis of AD, dementia, or related disorders. Participants will not be excluded based on gender, race, or ethnicity. There will be no upper age limit due to the heterogeneity of onset of AD/ADRD in individuals with ID

Where in United States

  • University of North CarolinaChapel Hill, United StatesContact: Brianne R Tomaszewski, Ph.D., MPHTaking people
  • University of ArkansasFayetteville, United StatesContact: Melissa N Savage, PhDNot yet recruiting

About the trial

What the trial wants to find out

Purpose: Conduct a wait-list randomized controlled trial (RCT) of an inclusive physical activity program called PACE for adults with intellectual disability (ID) who are not yet showing signs of Alzheimer's Disease (AD)/age-related dementias (ARD).

Read full original descriptionShow less

Participants: Participants include 120 adults with ID, their caregivers, and their coaches (up to 360 individual participants, grouped as triads), recruited through the University of North Carolina at Chapel Hill and the University of Arkansas. Participants also include 16 exercise professionals.

Procedures (methods): Each cohort will include 20 triads who are randomly assigned to the PACE program or the waitlist control group.

The 2 groups in the trial

  • PACE ProgramTreatment being tested

    The 16-week intervention includes: (1) a weekly group fitness class for adults with ID, (2) web-based training and resources for coaches and exercise professionals; (3) weekly coaching meetings for coaches and adults with ID, and (4) daily/weekly interactions with the PACE interactive web-based dashboard for adults with ID.

  • Waitlist ControlNo study treatment, for comparison

    Participants assigned to the Waitlist Control Group will not receive any intervention during this interval. Participants will receive the PACE Program after the completion of the 16-weeks for the Intervention Group.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Stage 1 Pilot Test for Feasibility and Efficacy of a Multi-Level Intervention to Increase Physical Activity in Adults With Intellectual Disability: Physical Activity and Community EmPOWERment (PACE)
Plain-language title
Physical activity program for adults with intellectual disabilityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
23 February 2026